Eckert & Ziegler Strahlen- und Medizintechnik AG announced that to expand its manufacturing capacities, Eckert & Ziegler plans to invest around ?10 million in its own site in Wilmington, MA. Eckert & Ziegler is thus positioning itself as an important supplier of lutetium-177 in the rapidly growing radioligand therapy market.
Market Closed -
Other stock markets
|
After market 10:18:16 pm | |||
47.36 EUR | -3.11% |
|
47.35 | -0.02% |
25/06 | German Stocks Fall Tuesday | DJ |
25/06 | Eckert & Ziegler Unit Gets 'Encouraging' Feedback from US FDA for Lead Diagnostic | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.67% | 1.09B | |
+2.11% | 7.42B | |
-11.88% | 4.32B | |
+0.16% | 3.15B | |
+11.71% | 2.16B | |
-35.95% | 958M | |
+7.20% | 927M | |
-54.85% | 682M | |
-35.14% | 632M | |
-27.54% | 624M |
- Stock Market
- Equities
- EUZ Stock
- News Eckert & Ziegler SE
- Eckert & Ziegler Strahlen- und Medizintechnik AG Announces Plans to Invest Around ? 10 Million in its Own Site in Wilmington